14. Cytomegalovirus

  1. Deepali Kumar MD, MSc, FRCPC and
  2. Atul Humar MD, MSc, FRCPC
  1. Raymund R. Razonable MD1 and
  2. Atul Humar MD, MSc, FRCPC2

Published Online: 5 MAY 2011

DOI: 10.1002/9781444397949.ch14

The AST Handbook of Transplant Infections

The AST Handbook of Transplant Infections

How to Cite

Razonable, R. R. and Humar, A. (2011) Cytomegalovirus, in The AST Handbook of Transplant Infections (eds D. Kumar and A. Humar), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444397949.ch14

Editor Information

  1. Transplant Infectious Diseases, University of Alberta, Edmonton, Canada

Author Information

  1. 1

    Transplant Infectious Diseases, Development and Diversity, Division of Infectious Diseases, College of Medicine, Mayo Clinic Rochester, MN, USA

  2. 2

    Transplant Infectious Diseases, University of Alberta, Edmonton, Canada

Publication History

  1. Published Online: 5 MAY 2011
  2. Published Print: 13 MAY 2011

ISBN Information

Print ISBN: 9780470658277

Online ISBN: 9781444397949

SEARCH

Keywords:

  • specific pathogens - cytomegalovirus;
  • prevention of cytomegalovirus (CMV) disease - in solid organ transplant (SOT) recipients;
  • type of transplant/modifying circumstance;
  • primary (preferred) strategy and agent;
  • alternative strategy and agent(s);
  • antiviral prophylaxis - being preferred, valganciclovir;
  • type of transplant/modifying circumstance;
  • treatment of acute rejection (if ALG is used);
  • interpretation of pediatric CMV serology - in donors and recipients <18 months;
  • treatment of CMV infection - and disease in SOT recipients

Summary

This chapter contains sections titled:

  • Prevention of cytomegalovirus (CMV) disease in solid organ transplant (SOT) recipients

  • Interpretation of pediatric CMV serology in donors and recipients <18 monthsa [1]

  • Algorithm for pre-emptive therapy of CMV in organ transplant recipients

  • Treatment of CMV infection and disease in SOT recipients

  • Suggested algorithm for the management of ganciclovir (GCV)-resistant CMV infection and disease